(login)

Leading pharmaceutical
company in the Baltic States

Stock news


2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
«Grindeks»: EU-funded Competence Centres Program is important to the development of Latvia’s national economy
07.02.2012
JSC «Grindeks» informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence Centre”.

Read more


«Grindeks»: currently we have 20 new products under development
06.02.2012
«Grindeks» informs that it is currently developing 20 new products. Among these are the new combinations of Mildronate® and generics.

Read more


Juris Bundulis appointed as Chairman of the Board of JSC «Grindeks»
09.01.2012
Juris-Bundulis
JSC «Grindeks» informs that the Supervisory Council has appointed Mr. Juris Bundulis as Chairman of the Board of JSC «Grindeks».

Read more


JSC «Grindeks» Foundation “For the Support of Science and Education” awards premiums to teachers, higher educational institutions` teaching staff and educational institutions
29.12.2011

JSC «Grindeks» Foundation "For the Support of Science and Education" informs thatt oday, on 29 December, it has awarded teachers, higher educational institutions` teaching staff and educational institutions for the significant contribution to promoting education. The total premium amount - 18,100 lats. Laureates - each teacher received a premium of 700 lats; higher educational institutions` teaching staff - premium of 1,000 lats, in its turn,  educational institutions received support premiums of 5,000 lats.

Read more


On publishing of JSC «Grindeks» non-audited interim consolidated financial statements in 2012
29.12.2011
JSC «Grindeks» plans to publish its non-audited interim consolidated financial statements:

Read more